Which has the lower trailing P/E, ABT or DOV?

DOV has the lower trailing P/E: ABT trades at 33.23 and DOV at 22.83. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, ABT or DOV?

Over the past five years, ABT grew revenue faster — ABT at a 2.98% CAGR versus DOV at 2.54%.

Does ABT or DOV pay a bigger dividend?

ABT yields 2.43% and DOV yields 1.10% based on trailing dividends and the latest price.

Is ABT or DOV more profitable?

DOV runs the higher net margin — ABT at 11.65% versus DOV at 13.48%.

How have ABT and DOV total returns compared?

Over the past 10 years, ABT delivered 11.61% and DOV delivered 14.80% annualized total return. Past performance doesn't predict future results.

Abbott Laboratories (ABT) vs Dover Corporation (DOV)

A side-by-side comparison of Abbott Laboratories and Dover Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 13, 2026. Differences are shown without an overall score or investment verdict.

Different business models: ABT is classified in Healthcare; DOV is classified in Industrials. Margin, capital intensity, and valuation differences should be interpreted in that sector context.

ABT

Abbott Laboratories

$178.82B

$103.34HealthcareDelayed quote: Sep 14, 2026, 3:55 PM EDT

DOV

Dover Corporation

$25.45B

$189.00IndustrialsDelayed quote: Sep 14, 2026, 3:55 PM EDT

Total return — ABT vs DOV

growth of $100 · dividends reinvested · last 10y

ABT +195.2% (+11.4%/yr)DOV +278.5% (+14.2%/yr)DOV compounded faster over this window

ABT DOV

ABT vs DOV: by the numbers

•ABT is the larger company ($178.82B vs $25.45B market cap).
•DOV trades at the lower trailing earnings multiple (22.83 vs 33.23 P/E), one valuation lens rather than an overall verdict.
•DOV converts more revenue to profit (13.48% vs 11.65% net margin).
•ABT grew revenue faster over the past five years (2.98% vs 2.54% CAGR).
•ABT pays the higher dividend yield (2.43% vs 1.10%).

Metrics side by side

Valuation

Metric	ABT	DOV
P/E ratio	33.23	22.83
Forward P/E	18.73	17.67
P/S ratio	3.84	3.02
P/B ratio	3.50	3.30
EV / EBITDA	18.95	14.88
FCF yield	4.43%	4.61%

Profitability

Metric	ABT	DOV
Gross margin	56.80%	39.58%
Operating margin	17.03%	16.87%
Net margin	11.65%	13.48%
ROE	10.61%	14.73%
ROIC	6.07%	9.56%

Dividends

Metric	ABT	DOV
Dividend yield	2.43%	1.10%
Payout ratio	79.74%	25.18%

Growth (annualized)

Metric	ABT	DOV
Revenue CAGR (5Y)	2.98%	2.54%
EPS CAGR (5Y)	8.22%	10.95%
FCF CAGR (5Y)	0.18%	2.55%
Total return CAGR (5Y)	-2.69%	2.98%

Frequently asked

Which has the lower trailing P/E, ABT or DOV?: DOV has the lower trailing P/E: ABT trades at 33.23 and DOV at 22.83. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, ABT or DOV?: Over the past five years, ABT grew revenue faster — ABT at a 2.98% CAGR versus DOV at 2.54%.
Does ABT or DOV pay a bigger dividend?: ABT yields 2.43% and DOV yields 1.10% based on trailing dividends and the latest price.
Is ABT or DOV more profitable?: DOV runs the higher net margin — ABT at 11.65% versus DOV at 13.48%.
How have ABT and DOV total returns compared?: Over the past 10 years, ABT delivered 11.61% and DOV delivered 14.80% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ABT analysis Full DOV analysis Interactive comparison tool

Dig into the metrics

Abbott Laboratories P/E ratio Dover P/E ratio Abbott Laboratories dividend yield Dover dividend yield Abbott Laboratories ROE Dover ROE Abbott Laboratories operating margin Dover operating margin Abbott Laboratories revenue growth Dover revenue growth Abbott Laboratories free cash flow Dover free cash flow

Abbott Laboratories & Dover appear in these rankings

Highest Dividend Yield Stocks 25+ Year Dividend Growers Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 13, 2026.